These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19039052)

  • 1. The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels.
    Kaplan SL; Mandel SJ; Muller R; Baloch ZW; Thaler ER; Loevner LA
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):608-12. PubMed ID: 19039052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
    Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary thyroid cancer: controversies in the management of neck metastasis.
    Davidson HC; Park BJ; Johnson JT
    Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retropharyngeal node metastasis from papillary thyroid carcinoma.
    Otsuki N; Nishikawa T; Iwae S; Saito M; Mohri M; Nibu K
    Head Neck; 2007 May; 29(5):508-11. PubMed ID: 17120310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
    Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
    Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
    Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-123-guided excision of metastatic papillary thyroid cancer.
    Khandelwal S; Sener SF; Purdy L; Perlman RM
    J Surg Oncol; 2007 Aug; 96(2):173-5. PubMed ID: 17443733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D; Mazzarotto R; Casara D
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
    Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
    Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
    Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.
    Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT
    Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.